COVID-19 Pandemic and Parents of Disabled Children

October 31, 2020 updated by: Berrin Hüner, Gaziosmanpasa Research and Education Hospital

COVID-19 Pandemic From the Perspective of Parents of Disabled Children

Pandemic period could affect the disabled children's rehabilitation and follow-up negatively because of preventive measures and this could create adverse results on their parents.

In this research, it is aimed to determine the positive and negative effects of pandemic on parents and disabled children and to provide an insight for future solutions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To determine the effect of COVID-19 pandemic and the possible difficulties experienced by the parents of disabled children, a questionnaire was prepared. It takes approximately 10-15 minutes to complete the survey. Questionnaire is loaded to qualtrics program and sent to the families by e-mail or social media accounts.

Study Type

Interventional

Enrollment (Actual)

309

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Gaziosmanpasa
      • İstanbul, Gaziosmanpasa, Turkey, 34255
        • Health Science University Gaziosmanpasa Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Having disabled child/children
  • Having ability and facility to use internet
  • Having ability to read and write
  • Having enough cognitive capacity to answer the questionnaire
  • To accept to participate the research

Exclusion Criteria:

  • Not having disabled child/children
  • Not having ability and facility to use internet
  • Not having ability to read and write
  • Not having enough cognitive capacity to answer the questionnaire
  • Not to accept to participate the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Parents who have a disabled child or children
Parents having disabled child or children will be included in the research and it will be wanted to complete the survey questionary
Other: Difficulties lived by disabled children's parents in the period of COVID-19 pandemic
It will be a cross sectional study to obtain the information on difficulties lived by disabled children's parents during recent pandemic period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A questionnaire that we created will be used to determine the difficulties experienced by disabled children's parents during Covid 19 pandemic related to their medical follow-up
Time Frame: 4 weeks
Difficulties related to rehabilitation facilities, other medical conditions or ortosis could increase because of Covid 19 pandemic unique conditions
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Fear of COVID-19 Scale
Time Frame: 4 weeks
The Fear of COVID-19 Scale, a seven-item scale, has robust psychometric properties. It is reliable and valid in assessing fear of COVID-19 among the general population and will also be useful in allaying COVID-19 fears among individuals. Score is minimum 7 pointts and maximum 35 points.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Gaziosmanpasa Research and Education Hospital

Investigators

  • Principal Investigator: Resa Aydin, Professor, Istanbul University Istanbul Faculty of Medicine
  • Principal Investigator: Evrim Karadağ Saygı, Professor, Marmara University Faculty of Medicine
  • Principal Investigator: Özden Özyemisçi Taşkıran, Professor, Koc University Faculty of Medicine
  • Principal Investigator: Nalan Çapan, Professor, Istanbul University Istanbul Faculty of Medicine
  • Study Director: Ebru Yilmaz Yalçınkaya, Professor, Health Science University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 5, 2020

Primary Completion (Actual)

August 30, 2020

Study Completion (Actual)

September 15, 2020

Study Registration Dates

First Submitted

June 28, 2020

First Submitted That Met QC Criteria

August 23, 2020

First Posted (Actual)

August 25, 2020

Study Record Updates

Last Update Posted (Actual)

November 3, 2020

Last Update Submitted That Met QC Criteria

October 31, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 105

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study protocol was established by Berrin Huner and Ebru Yilmaz Yalcınkaya Statistical analysis (Power analysis) was established by Ozden Ozyemisci Taskiran Informed consent was written by Berrin Huner

IPD Sharing Time Frame

Research is planned to bu conducted between June 15 th and July 15 th 2020. After 15 th of July in 1 week coming statistical analysis will be finished and than in 3 weeks article will be written

IPD Sharing Access Criteria

In necessary cases colleced data from the research will be shared with the local ethical committe

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on Difficulties lived by disabled children's parents in the period of COVID-19 pandemic

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe